Cost effectiveness of pneumococcal vaccination among Dutch infants: economic analysis of the seven valent pneumococcal conjugated vaccine and forecast for the 10 valent and 13 valent vaccines

Objectives To update cost effectiveness estimates for the four dose (3+1) schedule of the seven valent pneumococcal conjugated vaccine (PCV-7) in the Netherlands and to explore the impact on cost effectiveness of reduced dose schedules and implementation of 10 valent and 13 valent pneumococcal vacci...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	BMJ 2010-06, Vol.340 (7760), p.1347-1347
Hauptverfasser:	Rozenbaum, Mark H, Sanders, Elisabeth A M, van Hoek, Albert Jan, Jansen, Angelique G S C, van der Ende, Arie, van den Dobbelsteen, Germie, Rodenburg, Gerwin D, Hak, Eelko, Postma, Maarten J
Format:	Artikel
Sprache:	eng
Schlagworte:	Age Child, Preschool Cost control Cost effectiveness Cost effectiveness analysis Cost efficiency Cost estimates Cost Savings Cost-Benefit Analysis Decision Trees Ear diseases Economic analysis Economics Fatalities Grants Hearing loss Heptavalent Pneumococcal Conjugate Vaccine Humans Immunization Infant Infant, Newborn Infants Meningitis Models, Economic Netherlands Pneumococcal Infections - economics Pneumococcal Infections - prevention & control Pneumococcal Vaccines - economics Pneumonia Quality adjusted life years Quality of life Scholarly publishing Surveillance Treatment Outcome Vaccination Vaccines
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!